24:I[7748,["268","static/chunks/aaea2bcf-705c747c36d33c22.js","839","static/chunks/839-631463a41726f237.js","320","static/chunks/320-fa817057570f2b68.js","551","static/chunks/app/article/%5Bid%5D/page-b53fad440e632bf3.js"],"default"] 25:I[6437,["268","static/chunks/aaea2bcf-705c747c36d33c22.js","839","static/chunks/839-631463a41726f237.js","320","static/chunks/320-fa817057570f2b68.js","551","static/chunks/app/article/%5Bid%5D/page-b53fad440e632bf3.js"],"default"] 28:I[5504,["268","static/chunks/aaea2bcf-705c747c36d33c22.js","839","static/chunks/839-631463a41726f237.js","320","static/chunks/320-fa817057570f2b68.js","551","static/chunks/app/article/%5Bid%5D/page-b53fad440e632bf3.js"],"default"] 26:T79d,

SEOUL, South Korea, Oct. 18, 2023 /PRNewswire/ -- Yuyu Pharma will be attending CPHI Worldwide in Barcelona, Spain from October 24^th to October 26^th.

The Yuyu Business Development team will be able to meet great partners at booth #7G30 in the Korean Trade Association pavilion to introduce Yuyu's export products such as its modified new drug Maxmarvil EC Tablet, Yuhylyx soft capsules, Yuvaro, and Senuvela Tab, among others.

In particular, Yuyu will focus on promoting projects currently under development, such as a reduced sized Dutasteride and Dutasteride-Tamsulosin combination drug. These projects are being developed with the goal of entering the U.S. and European Benign Prostate Hyperplasia

Danny Kang, Export Manager at Yuyu said "As always, we look forward to having active discussions with partners at our CPHI booth. And hope to meet new potential partners as well"

About Yuyu Pharma

With over 80 years in the healthcare industry, Yuyu Pharma (KRX: 000220) is a rapidly scaling global pharmaceutical company founded in Seoul, South Korea. Yuyu is committed to developing innovative therapeutics in the areas of neurology, der

Images

Tags

More Like This

Daewoong Pharmaceutical to Participates in CPHI Worldwide 2023, Showcasing Own Novel Drug in the Global Market

SK pharmteco to showcase its extensive APIs and CGT capabilities in CPHI 2023

Kexing Biopharm Attended CPHI Worldwide 2023

Kexing Biopharm made its appearance at CPHI Milan 2024: Launch Ceremony for Apexelsin® in EU market Successfully done

Biocytogen/Eucure Biopharma to Present Complete Clinical Data from YH003 (anti-CD40 mAb) Phase I Trial at ESMO 2023

2024 International Pharmaceutical Cooperation High-End Forum Kexing Biopharm's Series of Globalization Activities (China) Successfully Concluded

SUANFARMA announces a collaboration with Reyoung Pharmaceutical to expand the existing portfolio of anti-infective and antibacterial products

OKYO Pharma Announces Participation in May 2024 Investor Conferences